Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic hypogastric nerve
F Raspagliesi, A Ditto, R Fontanelli, E Solima… - Gynecologic …, 2004 - Elsevier
Objectives. Recently, a nerve-sparing radical hysterectomy has been proposed for cervical
cancer to reduce morbidity. The aim of this study is (i) to describe the surgical anatomy of the …
cancer to reduce morbidity. The aim of this study is (i) to describe the surgical anatomy of the …
Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva
F Raspagliesi, F Hanozet, A Ditto… - Obstetrical & …, 2006 - journals.lww.com
Approximately 4% of gynecologic cancers are invasive carcinomas of the vulva. This
retrospective study was intended to determine the prognostic importance of clinical variables …
retrospective study was intended to determine the prognostic importance of clinical variables …
Type II versus Type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions
F Raspagliesi, A Ditto, R Fontanelli, F Zanaboni… - Gynecologic …, 2006 - Elsevier
OBJECTIVES: According to our previous experience, Type III Nerve-sparing Radical
hysterectomy (NSRH) for cervical cancer presented an acceptable urologic morbidity …
hysterectomy (NSRH) for cervical cancer presented an acceptable urologic morbidity …
[HTML][HTML] Percutaneous high frequency microwave ablation of uterine fibroids: systematic review
AM Ierardi, V Savasi, SA Angileri, M Petrillo… - BioMed Research …, 2018 - hindawi.com
Uterine fibroids are the most common benign pelvic tumor of the female genital tract and
tend to increase with age; they cause menorrhagia, dysmenorrhea, pelvic pressure …
tend to increase with age; they cause menorrhagia, dysmenorrhea, pelvic pressure …
Nerve-sparing radical hysterectomy in cervical cancer: evolution of concepts
F Raspagliesi, A Ditto, F Hanozet, F Martinelli… - Gynecologic …, 2007 - Elsevier
OBJECTIVES.: This paper reviews the evolution of concepts concerning the nerve-sparing
radical hysterectomy (NSRH) in cervical cancer. METHODS.: Research studies published …
radical hysterectomy (NSRH) in cervical cancer. METHODS.: Research studies published …
Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study
A Ditto, F Martinelli, C Borreani, S Kusamura… - International Journal of …, 2009 - ijgc.bmj.com
Background: To compare quality of life and bladder, intestinal, and sexual dysfunctions in 2
groups of patients undergoing different types of radical hysterectomies (RHs). Methods …
groups of patients undergoing different types of radical hysterectomies (RHs). Methods …
In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy
A Esseridou, G Di Leo, LM Sconfienza… - Investigative …, 2011 - journals.lww.com
Objectives: To assess the clinical feasibility of 3-dimensional (3D) proton magnetic
resonance spectroscopy (MRS) of ovarian masses at 1.5 T. Materials and Methods: We …
resonance spectroscopy (MRS) of ovarian masses at 1.5 T. Materials and Methods: We …
Microinvasive squamous cell cervical carcinoma
F Raspagliesi, A Ditto, E Solima, P Quattrone… - Critical reviews in …, 2003 - Elsevier
Several histologic tumor-related features are the key factors for further treatment planning in
microinvasive cervical cancer (MIC) after conization. To better define the indications for …
microinvasive cervical cancer (MIC) after conization. To better define the indications for …
Hysteroscopy in endometrial cancer: new methods to evaluate transtubal leakage of saline distension medium
E Solima, V Brusati, A Ditto, S Kusamura… - American journal of …, 2008 - Elsevier
OBJECTIVE: This study was undertaken to evaluate transtubal fluid leakage after low
pressure office saline solution hysteroscopy. STUDY DESIGN: Forty stage I/II endometrial …
pressure office saline solution hysteroscopy. STUDY DESIGN: Forty stage I/II endometrial …
Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane
F Raspagliesi, F Zanaboni, F Vecchione, F Hanozet… - Oncology, 2005 - karger.com
Objectives: The aimof this multicenter feasibility study was to determine the toxicity profile
and antitumor activity of the gemcitabine plus oxaliplatin combination as second-line …
and antitumor activity of the gemcitabine plus oxaliplatin combination as second-line …